Shannon James Samuel — SEC Form 4 filings
SEC reporting owner CIK 1485417. 9 Form 4 filings on record with FilingPulse; latest filed 2026-06-12.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-05-17 to 2026-06-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 2 filings — 75,000 shares, $92,035 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: purchase of 5,000 shares @ $8.79 ($43,950) in Xilio Therapeutics, Inc., filed 2026-03-30.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Xilio Therapeutics, Inc. (XLO) | Director | 5 | 3 legs · 75,000 sh · $92,035 | — | 3 |
| MANNKIND CORP (MNKD) | Director | 4 | — | — | 5 |
Form 4 filings — Shannon James Samuel
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-12 | 4 | Xilio Therapeutics, Inc. (XLO) | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2026-05-22 | 4 | MANNKIND CORP (MNKD) | Grant/award (A): 82,781 (derivative) @ $0 · Grant/award (A): 16,556 (derivative) @ $0 | EDGAR |
| 2026-03-30 | 4 | Xilio Therapeutics, Inc. (XLO) | Purchase (P): 5,000 @ $8.79 | EDGAR |
| 2026-03-03 | 4 | MANNKIND CORP (MNKD) | Grant/award (A): 12,000 @ $3.27 | EDGAR |
| 2025-06-18 | 4 | Xilio Therapeutics, Inc. (XLO) | Purchase (P): 45,000 @ $0.69 · Purchase (P): 25,000 @ $0.69 | EDGAR |
| 2025-06-12 | 4 | Xilio Therapeutics, Inc. (XLO) | Grant/award (A): 31,000 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | MANNKIND CORP (MNKD) | Grant/award (A): 52,854 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | Xilio Therapeutics, Inc. (XLO) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | MANNKIND CORP (MNKD) | Grant/award (A): 35,047 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1485417 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →